^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    IVX037

    i
    Other names: IVX037
    Associations

    News

    Trials
    Company:
    ImmVirx
    Drug class:
    RIG-I stimulant
    Related drugs:
    Associations

    News

    Trials
    3ms
    Study of Intratumoral IVX037 in Patients With Advanced or Metastatic Solid Tumours (clinicaltrials.gov)
    P1, N=70, Recruiting, ImmVirx Pty Ltd | N=40 --> 70 | Trial completion date: Sep 2024 --> Nov 2026 | Trial primary completion date: Sep 2024 --> Sep 2026
    Enrollment change • Trial completion date • Trial primary completion date • Metastases
    |
    MSI (Microsatellite instability)
    |
    Tyvyt (sintilimab) • IVX037
    over1year
    Study of Intratumoral IVX037 in Patients With Advanced or Metastatic Solid Tumours (clinicaltrials.gov)
    P1, N=40, Recruiting, ImmVirx Pty Ltd | Not yet recruiting --> Recruiting
    Enrollment open • Metastases
    |
    MSI (Microsatellite instability)
    |
    IVX037
    almost2years
    Study of Intratumoral IVX037 in Patients With Advanced or Metastatic Solid Tumours (clinicaltrials.gov)
    P1, N=40, Not yet recruiting, ImmVirx Pty Ltd | Initiation date: Sep 2022 --> Feb 2023
    Trial initiation date • Metastases
    |
    MSI (Microsatellite instability)
    |
    IVX037
    over2years
    Study of Intratumoral IVX037 in Patients With Advanced or Metastatic Solid Tumours (clinicaltrials.gov)
    P1, N=40, Not yet recruiting, ImmVirx Pty Ltd
    New P1 trial
    |
    MSI (Microsatellite instability)
    |
    IVX037